Güney-Varal İpek, Köksal Nilgün, Özkan Hilal, Bağcı Onur, Doğan Pelin
Department of Pediatrics, Division of Neonatology, Uludag University Faculty of Medicine, Bursa, Turkey.
Turk J Pediatr. 2017;59(1):13-19. doi: 10.24953/turkjped.2017.01.003.
Güney-Varal İ, Köksal N, Özkan H, Bağcı O, Doğan P. The effect of early administration of combined multi-strain and multi-species probiotics on gastrointestinal morbidities and mortality in preterm infants: A randomized controlled trial in a tertiary care unit. Turk J Pediatr 2017; 59: 13-19. Necrotizing enterocolitis (NEC) is a gastrointestinal emergency of the neonatal period. The aim of this study was to demonstrate the use of multistrain and multispecies probiotic on gastrointestinal morbidities and mortality. The study was organized as a randomized controlled, prospective study in premature infants (≤32 week and ≤1500 gram). The ready commercial preparations which contain multi-combined probiotics of Lactobacillus rhamnosus (4.1x10⁸ cfu) + Lactobacillus casei (8.2x10⁸ cfu) + Lactobacillus plantorum (4.1x10⁸ cfu) + Bifidobacterium animalis (4.1x10⁸ cfu) together with 383 mg of fructooligosaccharides and 100 mg of galactooligosaccharides as the prebiotic content, was administered enterally to the probiotic group (n=70); control group constituted of 40 preterms. Primary outcomes of the present study were ≥ Stage 2 NEC and the mortality. Secondary outcomes were culture-proven sepsis and days to reach full enteral feeding. All cases of NEC were seen in group 2 as 3.6% (n=4) of all infants. The mortality was found to be 1.4% (n=1) in Group 1 and 22.5% (n=9) in Group 2. The incidence of NEC and the mortality rate were found to be significantly lower in Group 1 (p=0.016, p=0.001, respectively). In Group 1, the NEC-related mortality rate and sepsis-related mortality rate were significantly lower than that of the control group (p=0.046, p=0.023). In this study, we showed that using probiotic strains in combined multistrain and multispecies forms at higher doses and for prolonged duration had positive effects on gastrointestinal complications, sepsis and mortality in premature infants.
居内伊 - 瓦拉尔I、克萨尔N、厄兹坎H、巴伊cı O、多ğan P。早期联合使用多菌株和多物种益生菌对早产儿胃肠道疾病及死亡率的影响:一项三级医疗单位的随机对照试验。《土耳其儿科学杂志》2017年;59:13 - 19。坏死性小肠结肠炎(NEC)是新生儿期的一种胃肠道急症。本研究的目的是证明多菌株和多物种益生菌在胃肠道疾病及死亡率方面的作用。该研究被组织为一项针对早产儿(≤32周且≤1500克)的随机对照前瞻性研究。将含有鼠李糖乳杆菌(4.1×10⁸ cfu)+干酪乳杆菌(8.2×10⁸ cfu)+植物乳杆菌(4.1×10⁸ cfu)+动物双歧杆菌(4.1×10⁸ cfu)的多种组合益生菌以及383毫克低聚果糖和100毫克低聚半乳糖作为益生元成分的市售现成制剂经肠道给予益生菌组(n = 70);对照组由40名早产儿组成。本研究的主要结局是≥2期NEC和死亡率。次要结局是经培养证实的败血症以及达到完全经口喂养的天数。所有NEC病例均出现在第2组,占所有婴儿的3.6%(n = 4)。第1组的死亡率为1.4%(n = 1),第2组为22.5%(n = 9)。第1组的NEC发病率和死亡率显著更低(分别为p = 0.016,p = 0.001)。在第1组中,NEC相关死亡率和败血症相关死亡率显著低于对照组(p = 0.046,p = 0.023)。在本研究中,我们表明以多菌株和多物种组合形式、高剂量且长时间使用益生菌菌株对早产儿的胃肠道并发症、败血症和死亡率有积极影响。